Immediate Impact
56 standout
Citing Papers
Overall Survival with Osimertinib in Resected EGFR -Mutated NSCLC
2023 Standout
Photo‐Reduction with NIR Light of Nucleus‐Targeting PtIVNanoparticles for Combined Tumor‐Targeted Chemotherapy and Photodynamic Immunotherapy
2022 Standout
Works of Lars Thaning being referenced
Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
2008
Prognostic Factors for the Survival of Surgically Treated Patients for Non-Small Cell Lung Cancer
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lars Thaning | 257 | 159 | 103 | 109 | 11 | 399 | |
| SA Gomm | 246 | 128 | 29 | 91 | 8 | 408 | |
| Güzin Gönüllü | 192 | 64 | 59 | 97 | 22 | 449 | |
| Ju‐Whei Lee | 262 | 105 | 68 | 27 | 10 | 447 | |
| Rajani Kaimal | 177 | 39 | 126 | 85 | 15 | 442 | |
| Dezong Gao | 234 | 55 | 70 | 101 | 19 | 418 | |
| Katherine Sharpe | 305 | 78 | 40 | 40 | 6 | 436 | |
| Prasun Subedi | 78 | 91 | 56 | 46 | 21 | 413 | |
| Peter Fox | 212 | 90 | 42 | 33 | 25 | 452 | |
| D Pharm | 115 | 148 | 186 | 45 | 12 | 430 | |
| E. E. Calle | 200 | 89 | 61 | 43 | 5 | 430 |
All Works
Loading papers...